About us

The Company Overview

Founded in 2004 as pharmaceutical solutions provider, our experience and operational flexibility allow us to offer our customers an overall and customized solution to address challenges in area of pharmaceutical regulations, product development services, engineering and market affairs.

At present, PharmSol has direct presence across Europe, Asia and Middle East through eight different PharmSol subsidiaries. With local presence in several geographies, PharmSol offers integrated solutions with ‘single window’ access to all its clients ensuring seamless and timely deliverance on all assignments.

We take pride in meticulously evaluating and judiciously interpreting the complex global pharmaceutical business environments and regulations.

Our service offerings, which can be provided on a supplemental or comprehensive basis and fully tailored for meeting the Product Development, IPR, Facility Design, Compliance, Registrations, Market Access and Supply Chain needs, with a focus on EU, US, TGA, WHO and other International Regulatory Requirements.


45+Product Developments
40+ Tech Transfers

25EU/US/WHO Facility

50+Analytical Methods

Our nimble processes and focused expertise empower us to conquer even the most challenging obstacles.

PharmSol not only conducts audits, but also deputes its experts at various client locations to manage the workload of compliance leading to successful inspections by various authorities including USFDA, EU, TGA, WHO etc. PharmSol aims to exceed clients' expectations in terms of responsiveness, lead time, customer service and cost effectiveness.

PharmSol enables its customers with practices that allow them to grow and develop high-quality products with efficiency and carry out operations that benefit customers in the long run.

Our Mission

Enabling access to Pharma business across the Globe.

 Our Vision

To be constantly valued by our customers for bringing Competent & Comprehensive Knowledge, Expertise and Solutions to their businesses.


  • Founding of Pharmaceutical Solutions FZCO, Dubai

  • Launch of the business model “Exclusive Sponsored Development On-Patent API’s”

  • Launch of “Contract Development of Formulations” and “Tech Transfer” services
  • Inception of Third Party Audits in response to the mandate of EC Directive 2004/27/EC

  • Founding of PharmSol Europe Limited, Malta

  • Founding of Pharmaceutical Solutions DMCC, Dubai
  • New office set-up in Dubai

  • Founding of Shanghai Rep. Office
  • Started exhibiting in CPhI China and CPhI Worldwide

  • Founding of PharmSol GmbH, Germany

  • Founding of PharmSol MPCC LLC, Dubai
  • Founding of PharmSol APAC Ltd., Hong Kong
  • Founding of PharmSol India Pvt. Ltd, India
  • Landmark of 500 GMP Audits since 2007 crossed

  • PharmSol GmbH becomes a member of BPI and VCI
  • PharmSol India receives ISO 9001:2008 Certification

  • Founding of PharmSol (Zhuhai) Pharmaceutical Technology Co., Ltd., China
  • Expansion of PharmSol India Setup
  • PharmSol’s 10 auditors certified as Independent Validators for CEIV Pharma (IATA)

  • Strategic Partnership with Chinese Clients

  • PharmSol India receives ISO 9001:2015 Certification
  • Landmark of 900+ audits crossed

  • Expansion of PharmSol India set-up to Ahmedabad, Gujarat
  • Founding of PharmSol (Nanjing) Pharmaceutical Technology Co., Ltd., Nanjing China

Management Team

Sunil Doshi

Managing Director

Managing Director

Sunil founded PharmSol in 2004 and led the company as Managing Director. His
C-level substantial expertise in all facets of Pharmaceutical Business, Diversity Management, International Business, Mergers & Acquisitions and Strategic Alliances brought PharmSol to operational level of excellence and growth.

A Chemical Engineer by qualification, with over 36 years of leadership experience in large pharma and established track record of entrepreneurial success within the pharmaceutical industry. Prior to founding PharmSol, he served for 20 years in various MNCs of repute. He has designed and mentored several green field projects for APIs and FDFs, all of which have been USFDA and/or EU certified.

S. Lakshminarasimhan

Chief Operating Officer

Chief Operating Officer

Lakshmi is the Chief Operating Officer of PharmSol Group, having responsibility for the company’s strategy function and stakeholder relationships including clients’ relations, and corporate responsibility.

He has over 26 years of diversified expertise and operational experience in Regulatory Affairs, QA, IPR, Bulk Drugs, Formulations and Fine Chemical Industries. Prior to his current role, Lakshmi worked in various Indian MNCs and International Companies.

Lakshmi is a Pharmaceutical Technologist with Post Graduate Diploma in Patent Law and an MBA in Operations, International Business. His professional accreditations include APIC Certified Auditor, Associate Member of European QP Association, ECA Certified Computer Validation Manager, formerly certified for Temperature - Controlled Cargo Operations and CEIV Pharma Independent Validator of IATA.

Christian Duchow



Christian has been a Director of PharmSol since inception. He is an entrepreneur with extensive experience in the pharmaceutical & allied fields, has been a guiding brain behind foundation of several businesses in Europe. At PharmSol, he has been supporting the strategy and business development functions.

He is a graduate in logistic operations and has transitioned into pharmaceuticals early in his career. His skills in leadership and expertise in assembling people together, while achieving essential aspirations have led to multiple achievements throughout the years.

Borut Strukelj

Senior Scientific Adviser

Senior Scientific Adviser

Borut holds a Post Doctorate in molecular biology and has a rich experience of over 35 years into the field of Biosimilar, Nano Technology, Biochemistry and Biotechnology. He was one of the key members of the committee on drafting the EU Guidelines on Biosimilar and was also appointed as an expert in European Pharmacopeia for biological pharmaceuticals as well as at the European Agency for Medicines in London (EMEA). Borut co-authored several patent applications and has written over 180 scientific and professional articles which were published in more than 100 leading scientific journals.

Currently, he is heading the Biotechnology Unit and is a full-time professor at the Faculty of Pharmacy of the University of Ljubljana. He is also a part of Editorial Board of the official journal of Slovenian Pharmaceutical Society and International Journal of Medicinal Mushrooms. As a Senior Scientific Adviser of PharmSol, he directs the PharmSol Team that focuses on the development, compliance, and regulatory aspects of biopharmaceutical projects.

Rajeev Patil



Rajeev is a technocrat with over 39 years of experience in the Pharmaceutical Industry of which a long stint of 31 years as Head of Global Regulatory Affairs at Lupin. He set a record for getting more than 170 approved ANDAs, guiding numerous successful US FDA inspections, more than 100 Market Authorizations in EU and Australia, prequalification of more than 15 products by WHO, playing significant role in all major regulatory audits of Lupin since 1989.

Currently as one of the Directors of PharmSol Group, he is involved in providing business solutions in Pharmaceuticals in the arena of Compliance, Regulatory and Project Management.

A postgraduate in Technology of Pharmaceuticals and having extensive experience in the Regulatory Affairs of Drug Products and APIs, Compliance Audits and Product Development (drug product as well as API) for US Markets.

Andrej Gasperlin

Senior Business Associate

Senior Business Associate

Andrej is a US based Pharmacist and Entrepreneur with a range of global experience. He brings to PharmSol a rich global experience of over 25 years within the areas of product development, cross licensing, technology transfers and strategic alliances negotiations and other related operations within the pharmaceutical industry.

He holds an Executive MBA degree in Pharmaceutical Marketing and has been supporting several international companies in the business of generics in the USA. He is also the Founder and President of AB Pharmaceuticals Inc.

He is an active member of the American Pharmaceutical Association as well as a member of the pharmaceutical technical committee in the Slovenian Pharmaceutical Association. He has been a member of the board of directors of the Generic Pharmaceutical Industry Association (GPIA) and member of several other committees of the Generic Pharmaceutical Association (GPhA).

Smita Kavishwar

Senior Vice President - Compliance and Regulatory Affairs

Senior Vice President - Compliance and Regulatory Affairs

Smita has over 24 years of experience in the Bulk Drugs and Specialty Chemical Industries in Quality Functions, Regulatory Affairs, IPR and Research & Development. She is currently the Vice President – Compliance and Regulatory Affairs of PharmSol Group, her main focuses are leading the Regulatory Affairs Department, managing registration and compliance of a large portfolio of products besides supporting GMP compliance and certification.

She holds a Ph. D. Tech (Pharmaceutical Chemistry) and Masters of Pharmaceutical Sciences. Her professional accreditations include Certification in IPR GNA Patent Gurukul, Certificate for ECA - Lab Data Integrity, APIC Certified, formerly certified for Temperature - Controlled Cargo Operations and CEIV Pharma Independent Validator of IATA.

Ravikanth Mandapati

Vice President - Quality Affairs

Vice President - Quality Affairs

Ravikanth is the Vice President – Quality Affairs of PharmSol Group. In this role, he heads the QA/QC functions, leading the execution team for several technology projects for Formulations and acting as the Chief Inspector of pre-dispatch inspections for API & Formulations.

With over 25 years of experience in the areas of Quality Control and Quality Assurance for Bulk Drugs & Formulations, Ravi has also worked across many areas of PharmSol providing support in the 3rd Party GMP Audits and EUGMP Certification projects of PharmSol and acted as Independent Validator towards CEIV Pharma of IATA.

He holds a Masters’ Degree in Chemistry and obtained a Diploma in Chemical Processing & Instrumentation Control and Certificates for ECA - Lab Data Integrity, APIC Auditor and CEIV Pharma Independent Validator of IATA.

Abhay Asthana

General Manager – Projects

General Manager – Projects

Abhay is the General Manager, Projects of PharmSol Group. He is leading the Product and Technology Development functions. He holds a Ph. D. in Pharmaceutical and has been into industry and academics for over 17 years. His professional expertise includes design and development of platform technology, formulation research, process efficiency enhancements, QBD guidelines, scientific community publications and IPR.

Medarametla Rambabu

General Manager – Technical Services

General Manager – Technical Services

Rambabu is the General Manager - Technical Services, looking after the manufacturing, tech transfer and outsourcing functions. He is a M. Pharm in Pharmaceutics and has over 20 years of core experience in pharma production, project management, facility design and upgrade among others.

Felix Huang

Director - China, BD

Director - China, BD

Felix, as Director – China Business Development, leads the business development and growth management functions for PharmSol in China. Prior to joining PharmSol, he has been into diverse roles including business development of CRO, marketing of food & nutraceutical ingredients, among others. He brings with him a strong network of Chinese pharma entrepreneurs.

He holds a degree in Information Technology from GD Industry Technical College, China.

Nancy Yao

Director - China, Technical Operations

Director - China, Technical Operations

Nancy has been one of early members of Team PharmSol based out of China and has since grown to become the Director of Technical Operations. She leads a team of compliance and technical experts of PharmSol in China. She has professional expertise in conducting GMP/QP audits, coordinating EU GMP Certifications and project management. Graduated from Shenyang Pharmaceutical University and has about 11+ years of experience in various technical regimes of pharmaceutical industry. She is qualified as an ASQ certified quality Auditor/APIC certified Auditor and Member of European Compliance Academy. As a certified lead auditor, she has successfully performed 200+ audits for various pharmaceutical companies manufacturing OSD, Sterile Dosage formulations and sterile and non-sterile API.

Shawn Xiao

Director - China, BD

Director - China, BD

Shawn has been with PharmSol for 8+ years as part of the Business Development and Commercial Operations in China. As Director – China Business Development, he played a key role in building the local set up of PharmSol in China.

With over 15 years of pharmaceutical industry experience with comprehensive expertise in sourcing, import and export of API and intermediates from China, he notably leads the PharmSol Team in dealing with overseas transactions and partnerships on supply chain.

Shawn obtained a Master’s Degree in Business Administration from Macau University.

Business Opportunities

  • We are eager to cooperate with all clients, partners and associates who match our values, work ethics and quality of work. We regard partnership and collaboration as an integral part of our business strategy.
  • Could you be one of them?
  • We shall be happy to be of assistance. Please contact one of our management team.
Contact Us

Our Establishments

PharmSol GmbH

Bad Oldesloe, Germany

PharmSol Europe Limited

Mosta, Malta

Pharmaceutical Solutions FZCO

Jebel Ali, Dubai, United Arab Emirates

Pharmaceutical Solutions DMCC

Jumeirah Lakes Towers, Dubai, United Arab Emirates

PharmSol India Pvt. Ltd.

Hyderabad, India

PharmSol (Nanjing) Pharmaceutical Technology Co.Ltd

Nanjing City, Jiangsu Province, PR China

PharmSol APAC Limited

Hong Kong, China